Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Deferred Taxes: 2022-2024

Historic Deferred Taxes for ProPhase Labs (PRPH) over the last 3 years, with Dec 2024 value amounting to -$14.6 million.

  • ProPhase Labs' Deferred Taxes fell 591.97% to -$14.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.2 million, marking a year-over-year decrease of 197.77%. This contributed to the annual value of -$7.2 million for FY2024, which is 197.77% down from last year.
  • According to the latest figures from Q4 2024, ProPhase Labs' Deferred Taxes is -$14.6 million, which was down 676.85% from $2.5 million recorded in Q3 2024.
  • ProPhase Labs' 5-year Deferred Taxes high stood at $3.0 million for Q4 2023, and its period low was -$14.6 million during Q4 2024.
  • In the last 3 years, ProPhase Labs' Deferred Taxes had a median value of $1.2 million in 2022 and averaged $13,583.
  • Data for ProPhase Labs' Deferred Taxes shows a peak YoY increase of 2,620.83% (in 2024) and a maximum YoY decrease of 591.97% (in 2024) over the last 5 years.
  • Over the past 3 years, ProPhase Labs' Deferred Taxes (Quarterly) stood at -$1.3 million in 2022, then skyrocketed by 321.28% to $3.0 million in 2023, then slumped by 591.97% to -$14.6 million in 2024.
  • Its Deferred Taxes stands at -$14.6 million for Q4 2024, versus $2.5 million for Q3 2024 and $2.3 million for Q2 2024.